Company: BLRX
Filing Date: 2025-03-31
Form Type: 20-F
Source: 0001178913-25-001123
Chunk: 158

Company: BioLineRx Ltd.
Filing Date: 2025-03-31
Form: 20-F
Item: Item 3
Chunk 158
---
109,400 ordinary shares issuable upon exercise of outstanding options                               

  (13)      See footnotes (3)-(12) for certain information regarding beneficial ownership.  

To our knowledge, other than as disclosed in the table above, our
other filings with the SEC and this Annual Report on Form 20-F, there has been no significant change in the percentage ownership held
by any major shareholder since January 1, 2022.

None of our shareholders has different voting rights from other shareholders.
We are not aware of any arrangement that may, at a subsequent date, result in a change of control of our company.

Record Holders

Bank of New York Mellon, or BNY, is the holder of record for the
Company’s American Depositary Receipt program, pursuant to which each ADS represents 600 ordinary shares. As of March 16, 2025,
BNY held 1,670,120,400 ordinary shares representing 74.8% of our issued share capital held at that date. Certain of these ordinary shares
were held by brokers or other nominees. As a result, the number of holders of record or registered holders in the United States is not
representative of the number of beneficial holders or of the residence of beneficial holders.

B. Related Party Transactions

The following is a description of the material terms of those transactions with related
parties to which we, or our subsidiaries, have been a party since January 1, 2024.

Agreements with Directors and Officers

Employment Agreements

We have entered into employment agreements with each of our executive
officers. See “ Item 6. B. Directors, Senior Management and Employees - Compensation.”

Options and Restricted Share Units.

We have granted, from time to time, options to purchase our ordinary
shares, RSUs and PSUs to our executive officers and directors. We describe our share incentive plan under “ Item 6. E. Directors,
Senior Management and Employees - Share Ownership - Equity Compensation Plan.”

Exculpation, Insurance and Indemnification

Our Articles of Association and Compensation Policy approved by
our shareholders permit us to exculpate, indemnify and insure our directors and office holders to the fullest extent permitted by law.
We have entered into agreements with each of our office holders exculpating them, to the fullest extent permitted by law, from liability
to us for damages caused to us as a result of a breach of duty of care, and undertaking to indemnify them to the fullest